Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Endothelial biomarkers as predictors for haemodialysis need in severe leptospirosis patients (Weil's disease)
Ist Teil von
Tropical medicine & international health, 2022-08, Vol.27 (8), p.727-734
Ort / Verlag
Oxford: Blackwell Publishing Ltd
Erscheinungsjahr
2022
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
Objective
To investigate the prediction ability of vascular injury biomarkers for haemodialysis requirement in patients with severe leptospirosis.
Methods
Prospective study with severe leptospirosis patients hospitalised in Fortaleza, Brazil. Blood samples were collected hospital admission to quantify vascular injury biomarkers: syndecan‐1, ICAM‐1, VCAM‐1, angiopoietin‐2 and FGF‐23. Two groups were evaluated according to haemodialysis requirement during hospital stay.
Results
Twenty‐seven patients were included, with a mean age of 39 ± 18 years. 88.9% were males. 53.8% needed haemodialysis and presented higher levels on hospital admission of syndecan‐1 (572 [300–811] vs. 263 [106–421] ng/ml; p = 0.03), angiopoietin‐2 (1.52 [0.72–2.72] vs. 0.63 [0.4–1.38] ng/ml; p = 0.01), and FGF‐23 (291 [56–2031] vs. 10 [10–806] pg/ml; p = 0.021). Syndecan‐1 showed significant correlation with creatinine (r = 0.546; p = 0.05) and total bilirubin levels (r = 0.534; p = 0.013) on hospital admission. Angiopoietin‐2 showed significant correlation with creatinine levels (r = 0.513; p = 0.009) on hospital admission and with number of haemodialysis sessions (r = 0.406; p = 0.049). No significant correlation was found with FGF‐23. Regarding prognostic performance, combined syndecan‐1 and angiopoietin‐2 levels had a better ability to predict haemodialysis need in patients with severe leptospirosis (AUC‐ROC = 0.744 [95% CI: 0.545–0.943] p = 0.035).
Conclusion
Syndecan‐1 and angiopoietin‐2 were associated with haemodialysis need in patients with severe leptospirosis and may be useful to improve therapeutic approach and reduce mortality.